TCL Archive DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts November 9, 1979
TCL Archive Taking on question of cost and outcomes, CMS turns to expert in cancer care quality. June 3, 2005
TCL Archive Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies November 28, 2014
TCL Archive FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer March 21, 2003
